Marianne S Carlon1, Alexander C Engels2,3, Barbara Bosch2,4, Luc Joyeux2, Marina G M C Mori da Cunha2, Dragana Vidović1, Zeger Debyser1, Kris De Boeck4, Arne Neyrinck5, Jan A Deprest6,7. 1. Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. 2. Department of Development and Regeneration, Organ System Cluster, KU Leuven, Leuven, Belgium. 3. Clinical Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Leuven, Belgium. 4. Department of Pediatric Pulmonology, University Hospitals Leuven, Leuven, Belgium. 5. Laboratory of Anesthesiology and Algology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. 6. Department of Development and Regeneration, Organ System Cluster, KU Leuven, Leuven, Belgium. jan.deprest@uzleuven.be. 7. Clinical Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Leuven, Belgium. jan.deprest@uzleuven.be.
Abstract
OBJECTIVES: The aim of this study was to assess the feasibility of fetal tracheal injection in the late-gestational pig to target the airways. METHODS: Following laparotomy and hysterotomy, fetoscopy was performed in pregnant sows to access the fetal trachea. Two volumes of fluospheres were injected (1 and 3 mL). Fluosphere distribution to the different lung lobes was investigated by microscopy. Possible fetal airway injury, caused by the surgical procedure or intratracheal injection, was investigated. Lung morphology and fetal lung volumes were calculated by micro computed tomography (μCT). RESULTS: Intratracheal administration was successfully performed in 20/21 fetuses. Analysis by confocal microscopy demonstrated that 3 mL, and not 1 mL, most efficiently targeted all lung lobes. On high-resolution μCT, total airway volume was estimated at 2.9 mL; strengthening that 3 mL is appropriate to target all lung lobes. No procedural damage was evidenced in the lungs or trachea. CONCLUSIONS: Intratracheal injection of nanoparticles is feasible in the pregnant pig and does not cause procedural lung damage. Using an injection volume of 3 mL, all lung lobes were efficiently targeted. This nanoparticle delivery model to fetal airways opens perspectives for therapeutic interventions.
OBJECTIVES: The aim of this study was to assess the feasibility of fetal tracheal injection in the late-gestational pig to target the airways. METHODS: Following laparotomy and hysterotomy, fetoscopy was performed in pregnant sows to access the fetal trachea. Two volumes of fluospheres were injected (1 and 3 mL). Fluosphere distribution to the different lung lobes was investigated by microscopy. Possible fetal airway injury, caused by the surgical procedure or intratracheal injection, was investigated. Lung morphology and fetal lung volumes were calculated by micro computed tomography (μCT). RESULTS: Intratracheal administration was successfully performed in 20/21 fetuses. Analysis by confocal microscopy demonstrated that 3 mL, and not 1 mL, most efficiently targeted all lung lobes. On high-resolution μCT, total airway volume was estimated at 2.9 mL; strengthening that 3 mL is appropriate to target all lung lobes. No procedural damage was evidenced in the lungs or trachea. CONCLUSIONS: Intratracheal injection of nanoparticles is feasible in the pregnant pig and does not cause procedural lung damage. Using an injection volume of 3 mL, all lung lobes were efficiently targeted. This nanoparticle delivery model to fetal airways opens perspectives for therapeutic interventions.
Authors: Xingshen Sun; Hongshu Sui; John T Fisher; Ziying Yan; Xiaoming Liu; Hyung-Ju Cho; Nam Soo Joo; Yulong Zhang; Weihong Zhou; Yaling Yi; Joann M Kinyon; Diana C Lei-Butters; Michelle A Griffin; Paul Naumann; Meihui Luo; Jill Ascher; Kai Wang; Timothy Frana; Jeffrey J Wine; David K Meyerholz; John F Engelhardt Journal: J Clin Invest Date: 2010-08-25 Impact factor: 14.808
Authors: J A Deprest; V A Evrard; E K Verbeken; A J Perales; P R Delaere; T E Lerut; H Flageole Journal: Eur J Obstet Gynecol Reprod Biol Date: 2000-09 Impact factor: 2.435
Authors: Liqiong Gui; Hong Qian; Kevin A Rocco; Loreta Grecu; Laura E Niklason Journal: Am J Physiol Lung Cell Mol Physiol Date: 2015-01-15 Impact factor: 5.464
Authors: Marianne Carlon; Jaan Toelen; Anke Van der Perren; Luk H Vandenberghe; Veerle Reumers; Lourenço Sbragia; Rik Gijsbers; Veerle Baekelandt; Uwe Himmelreich; James M Wilson; Jan Deprest; Zeger Debyser Journal: Mol Ther Date: 2010-07-27 Impact factor: 11.454
Authors: F I Luks; J A Deprest; K Vandenberghe; I Laermans; L De Simpelaere; I A Brosens; T Lerut Journal: J Am Coll Surg Date: 1994-06 Impact factor: 6.113
Authors: Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240